MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG, Pepa M, Isaksson LJ, Marvaso G, Raimondi S, Botta F, Gandini S, Ciardo D, Volpe S, Riva G, Rojas DP, Zerini D, Pricolo P, Alessi S, Petralia G, Summers PE, Mistretta FA, Luzzago S, Cattani F, De Cobelli O, Cassano E, Cremonesi M, Bellomi M, Orecchia R, Jereczek-Fossa BA.
Gugliandolo SG, et al. Among authors: bellomi m.
Eur Radiol. 2021 Feb;31(2):716-728. doi: 10.1007/s00330-020-07105-z. Epub 2020 Aug 27.
Eur Radiol. 2021.
PMID: 32852590
Clinical Trial.